The Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease
Article Sidebar
Main Article Content
ABSTRACT
Alzheimer’s disease is characterized by the formation and deposit of abnormal peptides such as amyloid plaques and neurofibrillary tangles in the brain. Therapeutic strategies aimed at preventing the formation of such deposits have not been successful. Currently, there are no effective treatments for the disease. Since numerous epigenetic changes have been detected in Alzheimer’s disease, treatments aimed at reversing these changes by intervening in DNA methylation, histone acetylation, and microRNA expression may constitute promising lines of research in the future. This chapter provides an overview of the epigenetic changes and the potential epigenetic therapies in Alzheimer’s disease.
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The books in their entirety are subject to copyright by the publisher. The reproduction, modification, republication and display of the books in their entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.